Search Results 661-670 of 16227 for pharmacogenetics
Rochester, Minn. The aim of this study is to develop a feasible, acceptable, and sustainable comprehensive cancer distress management program that is tailored ...
Mechanism of muscle wasting in aging; Plasma proteins as markers of insulin deficiency and diabetic complications. As a family physician and an endocrinologist, ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
About this study. The purpose of this study is to evaluate the dose, safety, immunogenicity and early clinical activity of GRT-C903 and GRT-R904, ...
The research involved a new blood test developed by Mayo Clinic to identify women at higher genetic risk for developing breast cancer. "The practice-changing ...
The purpose of this study is to develop a laboratory test to determine if an individual is at risk of developing antibodies to one of these two monoclonal ...
World Heart Day is September 29 ROCHESTER, Minn. — You may have heard of the mind-body connection: the broad concept that thoughts and feelings, especially[ ...
At the first U.S. 'Undiagnosed Hackathon,' scientists from around the world will team up at Mayo Clinic to solve unsolved medical mysteries. Young Julian Limon[ ...
Mayo Clinic offers PGY-1 and PGY-2 pharmacy residencies, a pharmacy internship, pharmacy technician program, and advanced pharmacy practice experiences.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.